CNX
49
3
EFX
54
2
VRTX
53
5
PLD
30
2
BF.B
48
-2
VIX
22
-14
FOX
68
2
CHRW
82
3
BA
47
4
RCL
68
4
STZ
42
-2
MTB
73
4
BIIB
50
4
NOV
52
4
UNM
65
-7
GS
76
6
AVB
34
-3
PFE
33
-8
L
71
2
V
52
2
CNX
49
3
EFX
54
2
VRTX
53
5
PLD
30
2
BF.B
48
-2
VIX
22
-14
FOX
68
2
CHRW
82
3
BA
47
4
RCL
68
4
STZ
42
-2
MTB
73
4
BIIB
50
4
NOV
52
4
UNM
65
-7
GS
76
6
AVB
34
-3
PFE
33
-8
L
71
2
V
52
2
Financhill
Back

Global X MSCI Greece ETF Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Buy
70

GREK
Global X MSCI Greece ETF

Last Price:
$67.34
Seasonality Move:
4.52%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Buy
70
Global X MSCI Greece ETF (GREK) is a Buy

Is Global X MSCI Greece ETF a Buy, Sell or Hold?

  • The current Global X MSCI Greece ETF [GREK] share price is $67.25. The Score for GREK is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • GREK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GREK Stock Price Chart

What is Global X MSCI Greece ETF's stock price today?

  • The Global X MSCI Greece ETF share price today is $67.25
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GREK is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.

GREK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.75 Buy
Relative Strength Index (14 RSI): 58.46 Buy
Chaikin Money Flow: -52324 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.45 - 67.19) Buy
Bollinger Bands (100): (63 - 66.14) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: 579058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.19 - 34.19) Buy

GREK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 67.05 Buy
20-day SMA: 66.34 Buy
50-day SMA: 64.67 Buy
200-day SMA: 58.72 Buy
8-day EMA: 66.88 Buy
20-day EMA: 66.25 Buy
50-day EMA: 64.17 Buy
200-day EMA: 41.14 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.82 Sell
20-day SMA: 34.8 Sell
50-day SMA: 33.74 Sell
200-day SMA: 33.57 Sell
8-day EMA: 17.59 Buy
20-day EMA: 8.61 Buy
50-day EMA: 3.75 Buy
200-day EMA: 0.98 Buy

Global X MSCI Greece ETF Earnings Growth & GREK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Global X MSCI Greece ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):